The prognostic significance of EMT-associated (TWIST1) and stem-cell (SC) transcript (CD24, CD44, ALDH1) quantification in EpCAM+ CTCs of early BrCa patients was examined in 100 early stage BrCa patients. This evidence concerns the gene TWIST1 and invasive breast carcinoma.